21 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2195111/here-s-why-you-should-retain-boston-scientific-bsx-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2195111
Dec 07, 2023 - Investors are optimistic about Boston Scientific (BSX) on strong worldwide demand for its GI and pulmonary treatment options and traction in Europe for its next-generation WATCHMAN FLX.
zc:-8921876035939019477
0